Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis

¹Departments of Pediatrics, Internal Medicine, Medical Microbiology and Immunology, Comprehensive Cancer Center, University of Wisconsin Medical School, Hospitals and Clinics, Madison, WI 53792, USA.

|October 24, 1998

Abstract:

People infected with Blastomyces dermatitidis develop strong immunity to the yeast surface adhesin WI-1, including antibody responses to the adhesive domain, a 25-amino-acid repeat, and cellular responses to the N terminus. We studied the immunogenicity of WI-1 and the ability of anti-WI-1 immune responses to protect against lethal pulmonary infection in mice. WI-1 immunization, given in Freund's adjuvant subcutaneously in two doses 2 weeks apart, evoked delayed hypersensitivity responses in a concentration-dependent manner. Immunized mice also had anti-WI-1 antibody responses, with titers reaching an endpoint dilution of approximately 1:800,000. Anti-WI-1 immunoglobulin G (IgG) antibody subclasses were IgG1 > IgG2b > IgG2a > IgG3, indicating a mixed T helper 1 and T helper 2 immune response. In protection experiments, WI-1 immunization significantly prolonged the survival of C57BL/6 and BALB/c mice compared to controls following intranasal administration of a lethal dose of B. dermatitidis yeasts (Kaplan-Meier survival curve P values of 0.027 to 0.0002) and also protected a proportion of the animals from death due to progressive pulmonary blastomycosis. Taken together, our results suggest that administration of WI-1 raises antibody and cell-mediated immune responses, which enhance resistance against pulmonary infection with B. dermatitidis. Mechanisms of vaccine-induced resistance require further investigation.

Related Experiment Videos

Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis

Related Concept Videos

R(3780) Resonance Interpreted as the 1^{3}D_{1}-Wave Dominant State of Charmonium from Precise Measurements of the Cross Section of e^{+}e^{-}→Hadrons.

Search for Rare Decays of D_{s}^{+} to Final States π^{+}e^{+}e^{-}, ρ^{+}e^{+}e^{-}, π^{+}π^{0}e^{+}e^{-}, K^{+}π^{0}e^{+}e^{-}, and K_{S}^{0}π^{+}e^{+}e^{-}.

Precise Measurement of Born Cross Sections for e^{+}e^{-}→DD[over ¯] at sqrt[s]=3.80-4.95 GeV.

First Observation of a Three-Resonance Structure in e^{+}e^{-}→Nonopen Charm Hadrons.

Determination of Spin-Parity Quantum Numbers of X(2370) as 0^{-+} from J/ψ→γK_{S}^{0}K_{S}^{0}η^{'}.

Observation of Structures in the Processes e^{+}e^{-}→ωχ_{c1} and ωχ_{c2}.

Tumor necrosis factor-α coordinates the macrophage innate immune response to Histoplasma capsulatum.

PgaR is a positive regulator of the pgaABCD biosynthetic operon in Klebsiella pneumoniae.

An intranasal bivalent vaccine induces antigen-specific humoral and Th1/Th17 cellular immunity and protects young and aged mice against MRSA and Pseudomonas aeruginosa skin and soft tissue infections.

The interface of biofilm and immune system for Gram-negative ESKAPE pathogens.

Modulating innate immune responses to curli fibers through protein engineering.

Carbon and nitrogen sources can fuel fungal virulence.

Toll-like receptors 7 and 8 as therapeutic targets for human diseases.

Self-Assembling Peptide-Adjuvant Conjugate (SaPAC) Platform for Precision Cancer Immunotherapy.

Optimizing antibody-dependent cellular phagocytosis for cancer immunotherapy: mechanisms, constraints, and therapeutic strategies.

Jianwei Shoutai Pills enhances maternal-fetal immune tolerance via regulatory T cell modulation to ameliorate uterine aging-associated early pregnancy loss.

IL-1 signaling in cancer-associated fibroblasts: shaping fibroblast heterogeneity, tumor immunity, and therapeutic resistance.

Inflammatory intensity and stimulus type induce distinct miRNA regulatory programs in bovine endometrial epithelial cells.

Related Experiment Videos

Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis

Abstract:

Related Concept Videos

Related Articles